Cargando…

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML

SIMPLE SUMMARY: Around 50% of patients with acute myeloid leukemia (AML) achieve a definite cure with intensive chemotherapy and consolidation, but relapse remains the main cause of death. Clonal hematopoiesis (CH) describes the presence of a clonal subset of myeloid precursors without known hematol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heini, Alexander D., Porret, Naomi, Zenhaeusern, Reinhard, Winkler, Annette, Bacher, Ulrike, Pabst, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267699/ https://www.ncbi.nlm.nih.gov/pubmed/34202404 http://dx.doi.org/10.3390/cancers13133190

Ejemplares similares

Autologous Transplantation for Older Adults with AML
por: Mueller, Beatrice U., et al.
Publicado: (2018)

Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
por: Valent, Peter, et al.
Publicado: (2019)

P1402: ALTERATIONS OF HUMAN BONE MARROW NICHE IN CLONAL HEMATOPOIESIS AND AML
por: Dragieva, Y., et al.
Publicado: (2022)

Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
por: Gurevich, Ekaterina, et al.
Publicado: (2022)

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
por: Seipel, Katja, et al.
Publicado: (2022)

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma
por: Heini, Alexander D., et al.
Publicado: (2022)

Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017)

Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
por: Rentsch, Vera, et al.
Publicado: (2022)

BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom’s Macroglobulinemia
por: Heini, Alexander D., et al.
Publicado: (2023)

Clonal Hematopoiesis and Vascular Disease
por: Amancherla, Kaushik, et al.
Publicado: (2022)

Discovering the drivers of clonal hematopoiesis
por: Pich, Oriol, et al.
Publicado: (2022)

Genetic Predisposition to Clonal Hematopoiesis
por: Quiros, Pedro M., et al.
Publicado: (2023)

Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation
por: Slavin, Thomas P., et al.
Publicado: (2019)

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
por: Mouhieddine, Tarek H., et al.
Publicado: (2020)

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
por: Shumilov, Evgenii, et al.
Publicado: (2021)

When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis
por: Bonadies, Nicolas, et al.
Publicado: (2021)

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
por: Dorsheimer, Lena, et al.
Publicado: (2018)

Aging of the Microenvironment Influences Clonality in Hematopoiesis
por: Vas, Virag, et al.
Publicado: (2012)

Clonal hematopoiesis in patients with rheumatoid arthritis
por: Savola, Paula, et al.
Publicado: (2018)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020)

CLONAL HEMATOPOIESIS IN A CENTENARIAN COHORT
por: Bhutkar, Aparna, et al.
Publicado: (2019)

Clonal hematopoiesis in sickle cell disease
por: Liggett, L. Alexander, et al.
Publicado: (2022)

Genetics of smoking and risk of clonal hematopoiesis
por: Levin, Michael G., et al.
Publicado: (2022)

Clonal hematopoiesis in primary immune thrombocytopenia
por: Wang, Yanming, et al.
Publicado: (2022)

Expanding approaches to detect clonal hematopoiesis
por: Khan, M.A. Wasay, et al.
Publicado: (2021)

Sex Differences in the Spectrum of Clonal Hematopoiesis
por: Kamphuis, Priscilla, et al.
Publicado: (2023)

Human Immunodeficiency Virus and Clonal Hematopoiesis
por: Vorri, Stamatia C., et al.
Publicado: (2023)

Clonal hematopoiesis in survivors of childhood cancer
por: Novetsky Friedman, Danielle, et al.
Publicado: (2023)

Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
por: Uddin, Md Mesbah, et al.
Publicado: (2022)

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients
por: Sanoyan, Dilara Akhoundova, et al.
Publicado: (2023)

Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series
por: Flach, Johanna, et al.
Publicado: (2020)

Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarction
por: Díez-Díez, Miriam, et al.
Publicado: (2022)

Clonal analysis of lineage fate in native hematopoiesis
por: Rodriguez-Fraticelli, Alejo E., et al.
Publicado: (2018)

Clonal hematopoiesis and risk of acute myeloid leukemia
por: Young, Andrew L., et al.
Publicado: (2019)

Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
por: Veiga, Camilla Bertuzzo, et al.
Publicado: (2021)

Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
por: Croitoru, Vlad M., et al.
Publicado: (2022)

Measures of Clonal Hematopoiesis: Are We Missing Something?
por: Bystrykh, Leonid V., et al.
Publicado: (2022)

Compartment-specific mutational landscape of clonal hematopoiesis
por: Hartmann, Luise, et al.
Publicado: (2022)

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
por: Stein, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_278nr7aih04m96lferhkvkl39k